AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 9, Pages 1174-1184
Publisher
Springer Nature
Online
2014-03-24
DOI
10.1038/onc.2014.50
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
- (2013) Albert Beckers et al. ENDOCRINE REVIEWS
- Aip regulates cAMP signalling and GH secretion in GH3 cells
- (2013) R Formosa et al. ENDOCRINE-RELATED CANCER
- Mutations Affecting G-Protein Subunit α11 in Hypercalcemia and Hypocalcemia
- (2013) M. Andrew Nesbit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
- (2012) Harvinder S. Chahal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aryl‐hydrocarbon receptor activity modulates prolactin expression in the pituitary
- (2012) Tyler B. Moran et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- AIP and its interacting partners
- (2011) Giampaolo Trivellin et al. JOURNAL OF ENDOCRINOLOGY
- A new therapeutic era for pituitary tumors
- (2011) Maria Gueorguiev et al. Nature Reviews Endocrinology
- PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascades
- (2011) Eduard Stefan et al. Nature Communications
- Mice with Inactivation of Aryl Hydrocarbon Receptor-Interacting Protein (Aip) Display Complete Penetrance of Pituitary Adenomas with Aberrant ARNT Expression
- (2010) Anniina Raitila et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Expression of AIP-Related Molecules in Elucidation of Cellular Pathways in Pituitary Adenomas
- (2009) Elina Heliövaara et al. AMERICAN JOURNAL OF PATHOLOGY
- G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor
- (2009) Asuka Nakata et al. EMBO REPORTS
- Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands
- (2008) G. Vlotides et al. CANCER RESEARCH
- Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VII
- (2008) Lily I. Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
- (2008) Chrysanthia A. Leontiou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
- (2008) Michael Grant et al. MOLECULAR ENDOCRINOLOGY
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now